Clinical Trial Update: Human Insulin NPH and Insulin Aspart in Type 1 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update investigates human insulin NPH and insulin aspart for Type 1 diabetes and notes the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NOVOLIN N (HUMAN INSULIN)
• NovoLog (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED